Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single doses of TAK-272, a novel renin inhibitor, in healthy male subjects

The requested reference [87702c0c442157f91752a2d2aea18f51de4da4aa] no longer exists in our database. It has been replaced by the current reference: [9e495dab46c7013708c88b2723ea1098ed48fb74]

Authors
Category Primary study
JournalNephrology Dialysis Transplantation
Year 2017
This article has no abstract
Epistemonikos ID: 4121f77378a1307ced99f7eb3c56cc593b27c788
First added on: Feb 08, 2025